IREN stock slides as AI data center push meets Nasdaq drop
IREN Limited fell 8.7% to $56.50 early Friday as the Nasdaq dropped and traders weighed its
Roadzen Stock Hovers Near $2 With Russell Index Move in Sight
Roadzen Inc traded at $1.895 in pre-market Friday, up 2.4%, valuing the company at about $149 million as it prepares to join Russell indexes this month. The company recently raised $8 million
STAAR Surgical up 5% in New York as China rebound is in focus after Alcon deal
STAAR Surgical shares rose 5.5% to $29.81 in New York, outpacing other eye-care stocks after a strong first-quarter rebound in China. The company ended its takeover talks with Alcon in January after shareholders rejected a $30.75 per share offer. No new company news was released Thursday. China accounted for 51% of STAAR's net sales last quarter.
Dragonfly Energy Stock Climbs After Battery Lawsuit Filing, But Cash Burn Clouds the Bounce
Dragonfly Energy shares rose 5.6% to $2.09 Thursday after the company filed a trade-libel lawsuit in Nevada against YouTuber Will Prowse and his business. The battery maker alleged Prowse published monetized, misleading reviews of its Battle Born Batteries and sought damages and injunctive relief. Dragonfly reported a first-quarter net loss of $7.7 million on sales down 27%. The stock traded between $1.97 and $2.13.
WTW Stock Jumps As AI, Dubai And Crypto Insurance Moves Pile Up
WTW shares climbed 2.7% to $257.86 in afternoon Nasdaq trading Thursday, rebounding from two days of losses. The move followed announcements of an AI workforce tool, a Dubai investment licence, and a digital-asset insurance acquisition. Peer insurance brokers also rose. WTW stock remains nearly 29% below its October 52-week high.
ImmunityBio Jumps Again as Traders Look to Anktiva News
ImmunityBio filed a Form 144 on June 4 to sell 268,033 common shares valued at about $2.95 million. Shares rose 3.0% to $7.395 in afternoon trading, with volume near 5.8 million. The FDA set a January 6, 2027, decision date for an expanded Anktiva bladder-cancer label. First-quarter net product revenue reached $44.2 million, up 168% from a year ago.
Applied Digital Stock Is Sliding — The AI Data-Center Bet Faces Its Next Test
Applied Digital Corp shares fell 2.6% to $43.57 Thursday as a Broadcom-led chip selloff weighed on AI-infrastructure stocks and the Nasdaq. The company’s market value stood at $12.3 billion with nearly 10 million shares traded. Recent contracts have boosted Applied Digital’s baseline revenue commitments to $31 billion, but the firm posted a $100.9 million net loss last quarter despite surging revenue.
Warner Bros. Discovery Faces $31 Merger Bar as Regulators Step In
Warner Bros. Discovery closed at $26.97 on Thursday, 13% below Paramount Skydance’s $31-a-share cash offer. Investors are awaiting a European Commission antitrust decision due by July 7. WBD shareholders have approved the $110 billion sale. Paramount’s legal team says regulatory reviews are standard and filings are in with authorities in Europe, Canada, the UK, and the US.
ICON Stock Jumps Again After Accounting Cloud Clears, One Risk Lingers
ICON plc shares rose 5.1% to $151.21 in New York after closing an accounting probe and restating revenue, which was overstated by 0.8% in 2023 and 1.1% in 2024. The company reported Q4 revenue of $2.11 billion and set 2026 revenue guidance below 2025 levels. Analysts raised price targets, and two new board members joined. ICON flagged ongoing material weaknesses in internal controls.
Boost Run Shares Fall After Filing Shows Growth, Spending Plans
Boost Run shares fell 9.9% to $34.33 in early Nasdaq trading Thursday after the AI-infrastructure company released new guidance and quarterly results. Q1 revenue jumped 165% to $10.96 million, but net loss widened to $4.12 million. Annual recurring revenue reached $96 million as of April 30, with a $360 million contracted backlog. The company recently signed a $471.7 million, 36-month deal with Thinking Machines Lab.
Warner Bros. Discovery Faces $31 Merger Bar as Regulators Step In
Warner Bros. Discovery closed at $26.97 on Thursday, 13% below Paramount Skydance’s $31-a-share cash offer. Investors are awaiting a European Commission antitrust decision due by July 7. WBD shareholders have approved the $110 billion sale. Paramount’s legal team says regulatory reviews are standard and filings are in with authorities in Europe, Canada, the UK, and the US.
ICON Stock Jumps Again After Accounting Cloud Clears, One Risk Lingers
ICON plc shares rose 5.1% to $151.21 in New York after closing an accounting probe and restating revenue, which was overstated by 0.8% in 2023 and 1.1% in 2024. The company reported Q4 revenue of $2.11 billion and set 2026 revenue guidance below 2025 levels. Analysts raised price targets, and two new board members joined. ICON flagged ongoing material weaknesses in internal controls.
Boost Run Shares Fall After Filing Shows Growth, Spending Plans
Boost Run shares fell 9.9% to $34.33 in early Nasdaq trading Thursday after the AI-infrastructure company released new guidance and quarterly results. Q1 revenue jumped 165% to $10.96 million, but net loss widened to $4.12 million. Annual recurring revenue reached $96 million as of April 30, with a $360 million contracted backlog. The company recently signed a $471.7 million, 36-month deal with Thinking Machines Lab.
Eikon Therapeutics Jumps Ahead of Biotech Peers
Eikon Therapeutics shares rose 5.1% to $9.91 late Thursday morning, still about 45% below the $18 IPO price from February. The company completed enrollment for its Phase 2 lung cancer trial, reporting a 63.1% objective response rate. Eikon ended Q1 with $596 million in cash but posted an $83 million loss. Analyst price targets averaged $24.80, with most maintaining a “Buy” rating.
Masimo Stock Is Stuck Just Below Danaher’s $180 Bid. The Gap Is the Story
Masimo shares traded at $178.78 before Thursday’s open, just below Danaher’s $180-a-share cash offer, as investors awaited regulatory clearance to close the $9.9 billion takeover. Shareholders approved the sale in May. The deal spread narrowed to about 0.7%. Nasdaq futures fell, but Masimo’s price tracked the pending merger rather than the broader market.
Unicycive shares edge up as biotech looks to June FDA meeting and analyst lifts target
Unicycive shares slipped 0.4% to $7.20 in premarket trading Thursday as investors awaited an FDA decision on oxylanthanum carbonate, due June 29. Benchmark raised its price target to $18. The company reported $57.1 million in cash as of May 11 and said it expects funding to last into 2027. No new company update has been issued since May 12.
Maywood Acquisition Corp. 2 Stock Trades Steady at $10 While Investors Watch Deal Timeline
Maywood Acquisition Corp. 2 shares rose 2 cents to $9.90 in light Nasdaq trading Friday, with only 19 shares changing hands by 11:29 a.m. EDT. The SPAC has not named a merger target and remains near its $10 IPO cash price. Investors can now split units into shares, rights, and warrants, trading under separate tickers. Broader U.S. stocks fell after payrolls data, with the Nasdaq Composite down 1.39% early.
XCF Global shares drop as CEO takes on chair role ahead of Nasdaq deadline
XCF Global Inc. shares fell about 8.5% to $0.4028 late Friday morning as the company named CEO Chris Cooper board chair and investors watched a looming Nasdaq delisting deadline. The stock has until June 8 to close above $1 for 10 straight days to regain compliance. XCF is preparing to restart its Reno refinery, targeting early June production. First-quarter net loss was $17.8 million on revenue of $348,688.
Red River Bancshares Moves Up Ahead of Dividend Record Date, Even as Wall Street Slips
Red River Bancshares shares rose 0.5% to $90.71 late Thursday, ahead of the June 8 record date for its $0.25 quarterly dividend. Director A. Peyton Bush IV reported direct ownership of 218 shares in a new SEC filing. First-quarter net income reached $12 million, or $1.81 per diluted share. Trading volume was 59,702.
MVB Financial Gains on June 5 as Bank Trade Lifts MVBF
MVB Financial shares rose 2% to $27.58 in light Nasdaq trading Friday, outpacing the SPDR S&P Regional Banking ETF’s 0.6% gain. The West Virginia bank reported Q1 net income of $5.2 million, or 39 cents a share, and will pay a $0.17 quarterly dividend June 15. Volume was just 5,196 shares. No new company news was released.
RedCloud Drops Under 60 Cents After Share-Sale Filings Push RCT Into Focus
RedCloud shares fell 10.2% to $0.55 on Friday, hitting a 52-week low after new SEC filings registered up to 50 million shares for possible resale. The filings raised dilution concerns, with the company’s share count potentially rising from 59.36 million to 109.36 million if all shares are issued. RedCloud remains under Nasdaq’s $1 minimum bid rule. Market cap stood near $32.7 million in late-morning trading.
Ironwood shares edge up as June debt test draws investor attention
Ironwood Pharmaceuticals shares rose 0.9% to $3.43 Friday morning after executives spoke at the Jefferies Global Healthcare Conference. The company faces the June 15 maturity of its 1.50% convertible notes. Ironwood reported first-quarter U.S. LINZESS net sales up 97% to $272.5 million, with $220.5 million in cash at quarter’s end. The FDA recently expanded LINZESS use to children as young as 2.
Saia gains after new freight numbers, target hikes still tempered by profit concerns
Saia shares rose 1.7% to $479.42 Friday morning on Nasdaq, outperforming the broader market as the S&P 500 and Nasdaq-100 ETFs fell. Second-quarter LTL tonnage per workday is up 7.6% year over year. Wells Fargo raised its target to $490, BMO to $470, and Benchmark maintained a $500 target. Saia recently opened new terminals, expanding its network to 216 locations.
Root Stock Edges Higher as Hugo Deal Puts Its Low-Cost Growth Bet on Display
Root, Inc. shares rose 1.4% to $53.38 Friday after announcing a new distribution deal with Hugo, even as the broader market fell. The partnership will route Hugo customers seeking full coverage to Root’s platform. Root reported first-quarter net income of $35.9 million and improved underwriting results. Progressive and State Farm still dominate the U.S. auto insurance market.
AVITA Medical Stock Is Moving: Shareholder Votes Put Cash, Warrants and Wound-Care Growth in Focus
AVITA Medical shares rose 0.8% to $4.395 early Friday after stockholders approved board, pay, and financing measures at the June 3 annual meeting. Investors backed equity awards for directors and warrants for Perceptive Credit Holdings. First-quarter revenue increased 4% to $19.3 million. Trading volume was thin, with about 11,500 shares changing hands versus a daily average of 229,000.
IREN stock slides as AI data center push meets Nasdaq drop
IREN Limited fell 8.7% to $56.50 early Friday as the Nasdaq dropped and traders weighed its Australian data-center plans. The company secured a $3.65 billion GPU financing facility to support a Microsoft AI cloud contract and plans a new 800-megawatt campus in South Australia. IREN is shifting focus from bitcoin mining to AI infrastructure, with major Nvidia chip orders and projected ARR growth to $4.4 billion.
Traws Pharma Dips as Company Expands Outbreak Drug Play
Traws Pharma shares fell about 5% early Friday to $1.40 amid a broader biotech slide after U.S. jobs data. The company reported a Q1 net loss of $7.1 million with $3.1 million in cash and no revenue, and is pursuing a $60 million PIPE deal. Traws is advancing a preclinical antiviral for Ebola, Lassa, and hantavirus, but has no human or animal efficacy data. An at-the-market program could add up to $3.13 million in new shares.
Chord Energy down on dividend date as oil swings
Chord Energy shares fell 2.6% to $136.50 Friday morning as the company paid a $1.30 per share dividend to holders of record May 20. Brent crude slipped 84 cents to $94.19 a barrel, while West Texas Intermediate dropped $1.13 to $91.91. Peer oil producers EOG, Diamondback, and APA also declined. Trading volume in Chord stayed light early in the session.
Tetra Tech Shares Flat, Traders Eye Backlog Number
Tetra Tech shares traded at $27.93, down 0.14% Friday morning in New York after opening at $28.37. The stock remains influenced by April’s raised guidance and a $4.28 billion backlog, but faces pressure from potential federal funding delays and a weaker market. No new company updates were issued. Neumeier Poma Investment Counsel recently increased its stake to 1.13 million shares.
Uranium Royalty Shares Dip Pre-Market With Sweetwater Deal Up for Review
Uranium Royalty Corp. shares fell 1.1% to $3.57 on Nasdaq Thursday, with premarket quotes at $3.53. Toronto shares closed at C$4.96. The company’s planned Sweetwater Royalties merger still requires shareholder approval. Spot uranium was quoted at $85 per pound on the company’s website.
Gemini Stock Is Up Before the Bell. Bitcoin’s Slide Is What Traders Are Really Watching
Gemini Space Station, Inc. shares rose 11 cents to $4.62 in premarket Nasdaq trading Friday, while bitcoin fell $1,732 to $61,944. The move came after Gemini’s recent $100 million capital raise from Winklevoss Capital, paid in bitcoin. Coinbase and Robinhood also traded higher before the bell. Nasdaq’s regular session had not yet opened.
Chenghe Acquisition III Shares Little Changed With $129M Trust Deadline Ahead
Chenghe Acquisition III Co. shares held at $10.15 before Friday’s Nasdaq open, near the trust value of $10.19 per share reported in March. The SPAC has not begun operations or reported revenue, with net income last quarter coming from trust interest. Warrants traded at $0.14. Chenghe must close a business combination by March 17, 2027, or risk liquidation.
Eco Wave Power Stock Trades Near High Ahead of Wall Street AI Move
Eco Wave Power Global AB’s American Depositary Shares last traded at $9.50, near their 52-week high, with only 339 shares changing hands Thursday. CEO Inna Braverman will present the company’s wave-energy technology to AI data-center investors at a Maxim Group summit on June 11. The company reported a $695,000 net loss for Q1 and $5.29 million in liquidity. Its Port of Los Angeles pilot has concluded; projects in Portugal and Israel continue.
Mercury Systems Stock Edges Toward 52-Week Peak as Wall Street Keeps Cautious View
Mercury Systems stock closed Thursday at $117.82, up 5.6% and just below its 52-week high, with a market cap near $7.0 billion. The company reported record Q3 bookings of $348 million, a 73.7% jump, and a $1.6 billion backlog, but remained unprofitable with a $3 million net loss. Shares traded above all published analyst price targets. Defense sector peers also gained in premarket trading.
Yunhong Green CTI shares await Nasdaq open with cash pressures in focus
Yunhong Green CTI Ltd. traded at $3.5801 in pre-market Friday, with just 4,070 shares changing hands. The company reported March quarter net sales up 28% to $6.154 million, but flagged “substantial doubt” about its ability to continue as a going concern. Cash stood at $178,000 with $13.387 million in liabilities. Three customers made up 90% of sales last quarter.
Verisk Stock Watches Hurricane Push as AI Uncertainty Lingers
Verisk Analytics shares traded flat at $180.00 in premarket Friday after closing up 0.94% Thursday. The stock remains over 44% below its 52-week high, but about 15% above its low. Verisk announced an updated U.S. Tropical Cyclone Model, set for release June 15. Director Samuel G. Liss exercised and sold 6,765 shares at $177.63 on June 2, now holding 69,098 shares.